Cerebrolysin for acute ischemic stroke

  • Protocol
  • Intervention

Authors

  • Lilia E Ziganshina,

    Corresponding author
    1. Kazan State Medical Academy , Department of Clinical Pharmacology and Pharmacotherapy, Kazan, Tatarstan, Russia
    • Lilia E Ziganshina, Department of Clinical Pharmacology and Pharmacotherapy, Kazan State Medical Academy , 11 Mushtari Street, 420012, 14-15 Malaya Krasnaya Street, 420015, Kazan, Tatarstan, Russia. lezign@mail.ru. lezign@gmail.com.

    Search for more papers by this author
  • Tatyana Abakumova,

    1. Kazan State Medical Academy, Department of Clinical Pharmacology and Pharmacotherapy, Kazan, Republic of Tatarstan, Russia
    Search for more papers by this author
  • Alexandra Kuchaeva

    1. Kazan State Medical Academy, Department of Clinical Pharmacology and Pharmacotherapy, Kazan, Republic of Tatarstan, Russia
    Search for more papers by this author

Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

(1) To assess the benefits and risks of cerebrolysin for treating acute ischemic stroke.
(2) To estimate the effect of cerebrolysin on survival and disability .
(3) To assess serious adverse events and adverse effects.

Ancillary